Sep 05, 2019
HINGHAM, Mass. , Sept. 05, 2019 (GLOBE NEWSWIRE) -- At the upcoming Rodman & Renshaw Global Investment Conference , Harel Gadot , CEO, President and Chairman of Microbot Medical Inc. (Nasdaq: MBOT), will demonstrate a working prototype of the Company’s Self-Cleaning Shunt (SCS™). Mr.
Jul 24, 2019
HINGHAM, Mass. , July 24, 2019 (GLOBE NEWSWIRE) -- As it continues to expand and diversify its Intellectual Property (IP) portfolio, Microbot Medical (Nasdaq: MBOT) announced that it has received a Notice of Allowance from the Israel Intellectual Property Office for Patent Application No .
Apr 23, 2019
HINGHAM, Mass. , April 23, 2019 (GLOBE NEWSWIRE) -- As it continues to receive an overwhelming positive response from global jurisdictions, Microbot Medical Inc. (NASDAQ: MBOT) expands its IP portfolio as it receives a Notice of Allowance from the Canadian Intellectual Property Office for Patent
Jan 23, 2019
HINGHAM, Mass. , Jan. 23, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into definitive agreements with institutional
Jan 17, 2019
HINGHAM, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT) demonstrated an activated Self-Cleaning Shunt (SCS TM ) during recent one-on-one investor and analyst meetings in San Francisco, which took place during the same week as the JP Morgan Healthcare conference.
Jan 15, 2019
HINGHAM, Mass. , Jan. 15, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into definitive agreements with several
Jan 15, 2019
HINGHAM, Mass. , Jan. 15, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into a definitive agreement with an institutional
Jan 14, 2019
HINGHAM, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Microbot Medical (NASDAQ: MBOT) announced today that it has validated the operational effectiveness of the Company’s Self-Cleaning Shunt (SCS TM ) in a recent independent in-vitro laboratory study. The Company also shared images of its SCS TM from
Jan 14, 2019
HINGHAM, Mass. , Jan. 14, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT), received a notification from the European Patent Office that it will grant a patent for Application No. 08738207, which covers the Company’s ViRob™ technology platform.

Displaying 118 - 126 of 154

Search Investor Relations